Thursday, September 22, 2016 3:39:21 PM
Recent TNXP News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2025 12:39:03 PM
- Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access • GlobeNewswire Inc. • 01/08/2025 12:00:00 PM
- Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences • GlobeNewswire Inc. • 01/07/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/03/2025 07:56:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 01:05:23 PM
- Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia • GlobeNewswire Inc. • 12/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2024 09:17:53 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/20/2024 09:16:37 PM
- This Micro Cap Is Getting Bid Up Prior To Opening Bell • AllPennyStocks.com • 12/17/2024 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 01:05:36 PM
- Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia • GlobeNewswire Inc. • 12/17/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/06/2024 09:13:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2024 12:05:23 PM
- Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires • GlobeNewswire Inc. • 12/03/2024 12:00:00 PM
- Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference • GlobeNewswire Inc. • 11/26/2024 12:00:00 PM
- Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual • GlobeNewswire Inc. • 11/18/2024 09:05:00 PM
- Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting • GlobeNewswire Inc. • 11/18/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:42:22 PM
- Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting • GlobeNewswire Inc. • 11/13/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 02:10:11 PM
- Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals • GlobeNewswire Inc. • 11/13/2024 02:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 10:10:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:05:29 PM
- Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM